Mondego Bio Launches with Series A Funding for AI-Driven Cancer Therapies

September 29, 2025
Mondego Bio, backed by Biovance Capital, Torrey Pines Investment, and OrbiMed, has launched to advance AI-driven cancer therapies.

Expert Systems Inc. has announced the launch of Mondego Bio, an emerging immuno-oncology company, with Series A funding. Announced in a press release, the new venture is supported by Biovance Capital, Torrey Pines Investment, and OrbiMed.

Mondego Bio is focused on developing a portfolio of first- and best-in-class PTPN2 inhibitors aimed at transforming cancer immunotherapy. These drug candidates have been designed and optimized using Expert Systems' AI/ML-driven molecular design and predictive pharmacology platform, significantly accelerating the path from concept to clinical readiness.

Expert Systems will continue to provide strategic, scientific, and technological support as Mondego Bio advances its pipeline into first-in-human studies. This collaboration underscores Expert Systems' capability to create and scale high-value biotech ventures, reducing early-stage innovation risks for investors and partners.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Funding News Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Funding

09/30
Rebellions Secures $250 Million in Series C Funding
09/29
Anything Achieves $100M Valuation with $11M Funding Round
09/29
Currency.com Relaunches with New Leadership and AI Initiatives
09/29
GoodFit Secures $13M to Enhance AI-Driven GTM Strategies
09/29
Black Forest Labs Seeks $4 Billion Valuation in New Funding Round

More from: Life Sciences

09/30
Natus Medical Acquires Full Ownership of Holberg EEG
09/29
Lumonus and Smarter Radiation Oncology Partner to Enhance Cancer Treatment
09/29
United Imaging Unveils AI-Enhanced Digital Radiography System
09/29
Vee Healthtek Acquires Precision Practice Management to Expand AI Healthcare Solutions
09/29
Qaelon Medical Adds Dr. Marylise Boutros to Advisory Board

Subscribe to AI Funding Brief

AI Token Webinar

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more

You May Also Like